Biopharma and biotech companies have launched more than 450 clinical trials into potential new treatments for cystic fibrosis (CF)…
Articles by Marisa Wexler, MS
The CFTR modulator therapy Kalydeco (ivacaftor) can safely be given to babies with cystic fibrosis (CF) as young…
While Kaftrio — sold as Trikafta in North America — can improve lung function in children with cystic…
Mutations that cause cystic fibrosis (CF) lead to biochemical changes in lung cells that make it easier for infectious…
The U.S. Food and Drug Administration (FDA) has given the go-ahead for a Phase 2 trial testing the inhalation therapy…
For adults with cystic fibrosis (CF), the symptoms with the biggest impact on quality of life include pain, fatigue,…
Bacteria in the airways of people with cystic fibrosis (CF) can interfere with the growth of Pseudomonas aeruginosa by…
4D Molecular Therapeutics (4DMT) is planning a Phase 3 clinical trial that, if results are positive, will be the…
Sionna Therapeutics has raised $182 million in financing to advance the development of small molecules designed to restore CFTR…
A lipid nanoparticle designed to deliver genetic therapy to lung cells could be used as a platform to treat lung-related…